Predicting Human Morbid and Druggable Genes Using Machine Learning
Author Information
Author(s): Costa Pedro R, Acencio Marcio L, Lemke Ney
Primary Institution: Instituto de Biociências de Botucatu, UNESP - Univ Estadual Paulista
Hypothesis
Can a machine learning approach accurately predict morbid and druggable genes on a genome-wide scale?
Conclusion
The study demonstrates that network topological features, tissue expression profiles, and subcellular localization can reliably predict human morbid and druggable genes.
Supporting Evidence
- The meta-classifier correctly recovered 65% of known morbid genes with a precision of 66%.
- It correctly recovered 78% of known druggable genes with a precision of 75%.
- Decision trees revealed that the number of regulating transcription factors is crucial for morbidity prediction.
Takeaway
Scientists used computers to find genes that can cause diseases or be targeted by drugs, making it easier to discover new treatments.
Methodology
A decision tree-based meta-classifier was trained on datasets containing network topological features, tissue expression profiles, and subcellular localization data.
Potential Biases
The lack of negative examples may lead to misclassification of unknown morbid genes as non-morbid.
Limitations
The approach relies on existing gene interaction data, which may not cover all human genes, and assumes that all genes not known to be morbid or druggable are non-morbid and non-druggable.
Statistical Information
P-Value
0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website